Aurinia Pharmaceuticals Inc (AUPH)
9.03
-0.01
(-0.11%)
USD |
NASDAQ |
Dec 20, 16:00
9.035
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Assets (Quarterly): 549.36M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Edesa Biotech Inc | 3.814M |
| Lexaria Bioscience Corp | 8.868M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 128.11M |
| ImmunoPrecise Antibodies Ltd | 43.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 161.36M |
| Shareholders Equity (Quarterly) | 388.00M |
| Current Ratio | 5.603 |